优化社区药房对乌干达的女性性工作者提供PrEP:混合方法研究协议
Ivan Segawa1, Katrina F Ortblad2,3, Herbert Kadama4
1Clinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda ivansegy@gmail.com.
BMJ open
|January 9, 2026
概括
坎帕拉的社区药房可以通过克服距离和有限的诊所时间等障碍,改善女性性工作者 (FSW) 获得艾滋病毒暴露前预防 (PrEP) 的机会. 这项研究评估了药房的容量和可访问性,以提供有效的PrEP.
科学领域:
- 公共卫生 公共卫生
- 实施科学 实施科学
- 地理空间分析是什么
背景情况:
- 乌干达的女性性工作者 (FSW) 面临高艾滋病毒感染风险,暴露前预防 (PrEP) 摄入量低于最佳水平.
- 基于设施的PrEP服务的障碍包括有限的临床时间,距离和FSWs之间的高流动性.
- 社区药房由于延长时间和方便的位置,有可能改善PrEP的可访问性.
研究的目的:
- 评估乌干达坎帕拉社区药房的可访问性和容量,作为向FSW提供PrEP的潜在地点.
- 为了比较社区药房提供的PrEP服务与公共医疗保健设施的覆盖范围和可访问性.
- 评估药房是否准备好整合PrEP服务,同时考虑基础设施,资源和工作人员的观点.
主要方法:
- 一个并发的混合方法研究,整合了地理空间绘图,结构化调查,离散选择实验 (DCE) 和深度访谈 (IDI).
- 地理空间分析以绘制药店,PrEP诊所,FSW热点和艾滋病毒发病率的地图,计算PrEP设施需求比例和旅行时间.
- 与FSW (n=50次调查,n=20-30次调查) 和药房工作人员 (n=274次调查,n=20-30次调查) 进行调查和IDI,以评估感知到的可访问性和药房能力.
主要成果:
- 地理空间分析将绘制服务覆盖范围,并确定最需要可访问PrEP服务的地区.
- 定量和定性数据将评估FSW的可访问性和药房提供PrEP的能力.
- 一个离散选择实验将确定药房工作人员对PrEP交付模式的偏好.
结论:
- 社区药房为坎帕拉的FSW提供 PrEP 的可行和可访问的选择,可能会增加吸收率.
- 调查结果将为政策和实践提供信息,以便将社区药房纳入艾滋病毒预防战略.
- 成功实施需要解决药房容量问题,并使交付模式与员工偏好和FSW需求保持一致.
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Dosage Regimens: Designs and Approaches
258
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
258
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
246
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
246
Methods for Studying Drug Absorption: In vitro
569
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
569
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235


